Clinical Trial Update: Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab with etoposide and cisplatin in breast cancer patients with brain and/or leptomeningeal metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Cisplatin (Platinol) (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Neoplasms, Leptomeningeal Metastasis | Phase 2 | Status: COMPLETED